News Releases


GWG Holdings Announces New Life Expectancy Methodology
Results from Life Expectancy Providers Announced Updates and Changes Life Expectancy tables Significantly Improves Actual-to-Expected Predictive Power   Implementation Results in a Non-Cash, Non-Recurring Charge of $84 million in Q4 2018 MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) -- GWG Holdings,
Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11
MINNEAPOLIS, March 07, 2019 (GLOBE NEWSWIRE) -- Life Epigenetics , a biotechnology company that discovers, quantifies and commercializes epigenetic signatures for use in the longevity, clinical research, pharmaceutical, and nutraceutical markets, announced that its Chief Executive Officer Jon Sabes